Clinical Trial Update: Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating conversion therapy for RAS/BRAF wild-type right-sided colon cancer with initially unresectable liver metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer, Liver Metastases | Phase 3 | Status: UNKNOWN